Skip to content

Add your earlier progress to your account?

From before you signed in, this browser has:

Which plan do you want to keep?

You answered the plan questions before signing in. These answers differ from the plan saved on your account.

SettingSaved planNew answers

Study progress is waiting to be saved

MicrobiologyLesson 7 of 19

Wound, Tissue, and Genital Tract Bacteriology

  • 32 min
  • 13 sections
  • 3 self-checks
On this page

Tissue, wound, and genital cultures recover the organism present in the lesion only when the specimen is collected from that site and processed for the pathogens expected there. Surface swabs of chronic ulcers and unenriched genital cultures recover colonizers as readily as pathogens, so the value of the culture result depends on how the specimen was collected.1,2

Specimen strategy by lesion type

Surgically obtained tissue recovers more organisms than a swab with limited absorptive capacity. Mince the tissue and, for routine bacterial culture, homogenize it to a suspension before inoculating all necessary media. When a mold infection is suspected, particularly from the Mucorales, mince or dice the tissue and do not grind it, because homogenization destroys fragile hyphae and lowers both culture and direct-microscopy yield. The surgeon, pathologist, and microbiology laboratory divide the material together, so that histopathology and culture each receive what they need.2

Lesion type Optimal specimen Processing notes
Fluid-filled skin lesions (vesicles, pustules, bullae, abscesses) Aspirated fluid (needle/syringe) Skin disinfection before aspiration for bacterial or fungal testing; skip disinfection if viral testing is planned, because antiseptics inactivate virus. Vesicles suggest HSV or VZV; pustules and generalized bullae suggest bacteria (especially Staphylococcus); foot-limited bullae suggest fungi
Wounds Aspirate, tissue biopsy, or curettage; avoid swabs when possible because surface swabs pick up skin commensals and confuse interpretation Gram stain plus culture on media appropriate to the suspected organism group. Tissue or aspirate from a deep wound should be placed in an anaerobic transport device when anaerobic culture is requested
Ulcers Varies by suspected cause (below) Secondary colonization of chronic ulcers by mixed aerobes and anaerobes is common. Deep tissue or aspirate after debridement is required because surface culture reflects colonizers

Gram stain interpretation and organism significance

Report the wound or tissue Gram stain with quantitated neutrophils and squamous epithelial cells. Many squamous epithelial cells indicate surface contamination. Abundant neutrophils support active infection. Note intracellular organisms specifically, because they support infection by a true pathogen. Reporting "no organisms seen" does not exclude infection, because a direct Gram smear detects roughly 105 organisms per milliliter, about the concentration at which one organism appears per oil-immersion field.1,12 Certain morphologies from a normally sterile site require immediate provider notification: gram-positive cocci in clusters suggesting Staphylococcus aureus in a deep abscess, large gram-positive rods suggesting Clostridium in gas gangrene, and gram-negative diplococci in a sterile-site aspirate.1,2

Organism significance depends on the specimen source. Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), and beta-hemolytic streptococci, especially Streptococcus pyogenes, are important potential pathogens in any wound and receive a full workup when recovered. Whether an isolate represents infection depends on specimen depth and the clinical evidence of infection, because a surface culture from a colonized chronic ulcer can grow either organism without invasion. Pseudomonas aeruginosa and the Enterobacterales are significant from deep tissue but common colonizers of superficial chronic wounds. Anaerobes are expected in mixed infection after mucosal or tissue disruption, particularly in bite wounds and deep abscesses. Coagulase-negative staphylococci and Corynebacterium are usually contaminants from skin but become significant in prosthetic-joint infection or when recovered repeatedly from a normally sterile site. Cutibacterium acnes requires extended incubation, up to 14 days, for recovery from prosthetic-shoulder and prosthetic-joint specimens. Report a polymicrobial superficial culture as mixed flora, with a note that full identification and susceptibility testing of every isolate is not indicated. Deep or normally sterile sources receive a complete workup.1,2

Necrotizing fasciitis and gas gangrene are surgical emergencies, and the laboratory communicates its findings immediately. A tissue or aspirate Gram stain showing gram-positive cocci in chains suggests S. pyogenes necrotizing fasciitis. Large boxcar gram-positive rods without neutrophils suggest clostridial myonecrosis. Aeromonas and Vibrio vulnificus cause necrotizing infection after water exposure, particularly in liver disease or immunocompromise. Clostridium perfringens grows rapidly, shows double-zone hemolysis on blood agar, and is positive in the reverse CAMP (Christie-Atkins-Munch-Petersen) test. Collect blood cultures in parallel.1,2

Ulcer-associated and bite/scratch organisms

Organism Lesion Diagnostic approach
Bacillus anthracis Cutaneous anthrax (black eschar) Sentinel rule-out and referral
Corynebacterium diphtheriae Cutaneous diphtheria: membranous ulcer Collect swabs from beneath the pseudomembrane edge, one for routine culture and one for cystine-tellurite selective agar. A Loeffler alkaline methylene-blue smear from overnight growth demonstrates the metachromatic granules and Chinese-letter arrangement more reliably than a direct smear. Forward any presumptive isolate to the public health laboratory for toxin-gene testing
Pseudomonas aeruginosa Ecthyma gangrenosum, classically associated with but not requiring pseudomonal bacteremia Punch or excisional biopsy of the violaceous advancing edge for Gram stain and aerobic, anaerobic, and fungal culture, with blood cultures in parallel. Similar lesions occur with other gram-negative rods, Candida, Aspergillus, and Fusarium in neutropenic hosts
Francisella tularensis Ulceroglandular tularemia Sentinel rule-out and referral
Mycobacteria (M. fortuitum, M. abscessus, M. chelonae, M. marinum, M. haemophilum, M. ulcerans) Chronic cutaneous ulcers/nodules Aspirate or tissue; a swab traps mycobacteria in its fibers, so do not use one. Notify the laboratory of suspected M. marinum, M. ulcerans, or M. haemophilum so that a second culture is incubated at 28 to 32 °C; these low-temperature growers are missed at routine 35 to 37 °C, and M. haemophilum also requires iron or hemin supplementation
Fungi Active ulcer margin Potassium hydroxide (KOH) or calcofluor white smear plus culture

Zoonotic and bite-wound organisms:

Bite wounds are polymicrobial. Infected dog and cat bites grow a median of 5 bacterial isolates per culture, a mixture of aerobes and anaerobes, so specimens for bite cultures are inoculated to media and incubated under conditions that recover both groups.1

Organism Reservoir/exposure Key laboratory features Disease
Pasteurella multocida and related species (P. canis, P. stomatis, P. dagmatis) Oral flora of cats and dogs; cat bites become infected more often than dog bites because narrow puncture teeth inoculate flora deeply Grows on blood and chocolate agar but not MacConkey; mousy or musty colony odor, though sniffing plates is not recommended practice; oxidase-positive, catalase-positive, indole-positive, nonmotile; typically penicillin-susceptible with a wide zone around a penicillin disk (CLSI M45 provides breakpoints). MALDI-TOF with a current library or 16S rRNA or sodA sequencing resolves the related species that biochemical panels misidentify Wound or soft-tissue infection after bite or scratch; can progress to bacteremia, osteomyelitis
Capnocytophaga canimorsus and C. cynodegmi Dog and cat oral flora Fusiform gram-negative rods, catalase-positive and oxidase-positive, unlike the catalase- and oxidase-negative human oral Capnocytophaga species (C. ochracea, C. gingivalis, C. sputigena, C. granulosa, C. haemolytica, C. leadbetteri); blood and chocolate agar with 5-10% CO2, slow growth often beyond 24 hours; may need blind subculture from blood-culture bottles; aminoglycosides are typically inactive in vitro, and β-lactamase has been reported in some isolates Wound infection and fulminant sepsis, especially after splenectomy or heavy alcohol use; also meningitis and endocarditis
Human oral Capnocytophaga (C. ochracea and related species listed above) Human oral flora Fusiform, oxidase-negative, catalase-negative Endogenous periodontal infection; septicemia and endocarditis in immunocompromised or previously healthy hosts
Eikenella corrodens Human oral flora; clenched-fist and human-bite wounds Bleach-like colony odor; pitting of the agar surface; oxidase-positive, catalase-negative; susceptible to penicillin but resistant to clindamycin, metronidazole, and oxacillin, so empirical antianaerobic coverage alone misses it Human-bite and clenched-fist infection; also endocarditis and head and neck infection
Bartonella henselae Cat scratch or bite; flea-borne among cats Fastidious; rarely cultured. Serology is the usual first test, with nucleic acid amplification testing (NAAT) on lymph-node aspirate or blood for confirmation Cat-scratch disease: regional lymphadenopathy with a primary inoculation papule
Erysipelothrix rhusiopathiae Swine, fish, poultry; occupational exposure among butchers, fishermen, and veterinarians Pinpoint gray-translucent colonies visible at 24-48 hours; weak narrow alpha-hemolysis may develop with prolonged incubation; nonhemolytic early. H2S-positive in TSI, unlike Listeria monocytogenes; nonmotile; catalase-negative, separating it from catalase-positive Listeria; distinctive test-tube-brush (pipe-cleaner) growth in a gelatin stab at 22 °C without liquefaction; urease, gelatin, and esculin negative; intrinsically resistant to sulfonamides, aminoglycosides, and vancomycin, a pattern shared with Leuconostoc, Pediococcus, and Lactobacillus Erysipeloid: localized violaceous hand or finger cellulitis; rare septicemia and endocarditis
Streptobacillus moniliformis Rat oral flora String-of-beads filamentous gram-negative rod; L-form colonies (fried-egg) alongside wild type; puff-ball growth in broth; requires media enriched with roughly 10-30% (commonly about 20%) blood or serum, incubated with 5-10% CO2; MALDI-TOF with an adequate library now identifies the species, with 16S rRNA sequencing as the fallback because commercial libraries under-represent this fastidious organism Rat-bite fever (bite) or Haverhill disease (ingestion of contaminated food, milk, or water): fever, migratory polyarthritis, and morbilliform rash. The other rat-bite fever cause, Spirillum minus (sodoku), is not culturable on artificial media and is diagnosed by darkfield or Giemsa-stained smear of blood or lesion material

Sentinel recognition and referral of B. anthracis and F. tularensis are covered with the select-agent lesson.

Nocardia and the aerobic actinomycetes

Nocardia morphology, identification, susceptibility testing, and pathogenicity are covered in mycobacteriology. Related aerobic actinomycetes include Rhodococcus equi (opportunistic granulomatous pneumonia, typically in severe immunosuppression; reclassified as Prescottella equi in 2022, though most US laboratories still report it as Rhodococcus equi), Gordonia and Tsukamurella (pathogenic mainly with a foreign body or underlying chronic infection), and Actinomadura and Streptomyces somaliensis (agents of actinomycotic mycetoma, chiefly in barefoot populations of tropical and subtropical regions). Tropheryma whipplei, the agent of Whipple disease, is not recovered by routine bacterial culture. Diagnosis is made from periodic acid-Schiff-positive foamy macrophages in duodenal biopsy, T. whipplei real-time PCR on tissue, blood, synovial fluid, CSF, or valve, and immunohistochemistry on paraffin-embedded tissue.

Actinomyces and actinomycosis

Actinomyces species are filamentous, gram-positive, fermentative anaerobes that colonize the mouth, tonsillar crypts, and female genital tract. Actinomycosis follows disruption of mucosa, producing a draining sinus or a hard mass in the cervicofacial region, thorax, abdomen, or pelvis, classically with an intrauterine device in place for pelvic disease. Collect tissue or aspirate. A swab of a draining sinus recovers the accompanying mixed flora and may miss the organism. Crush sulfur granules, visible macroscopically as yellow grains about 1 mm across, between slides and Gram-stain them to show branching, filamentous, gram-positive rods radiating from a center (Splendore-Hoeppli material surrounds true granules). Anaerobic culture requires enriched media and 5 to 7 days of incubation, with cultures kept for up to 2 to 3 weeks. Actinomyces is distinguished from Nocardia by modified acid-fast staining (negative versus positive) and anaerobic versus aerobic growth.1

Vaginal specimens: bacterial vaginosis and vulvovaginitis

Bacterial vaginosis (BV) is a polymicrobial vaginal dysbiosis in which hydrogen-peroxide-producing Lactobacillus species are replaced by high concentrations of Gardnerella species, Prevotella, Mobiluncus, Fannyhessea vaginae (formerly Atopobium vaginae), and uncultivated taxa including BVAB2 and Megasphaera type 1, growing in a polymicrobial biofilm on vaginal epithelial cells. BV is associated with preterm birth, pelvic inflammatory disease (PID), endometritis, and increased acquisition of other sexually transmitted infections. Vulvovaginitis is more often caused by Candida species or Trichomonas vaginalis. BV is the most common cause of vaginal discharge, and treatment is directed at symptomatic disease.3,2

Gram stain with a standardized scoring system (Nugent score) is the reference laboratory method for BV. At 1,000× oil immersion, representative fields are scored for three morphotype categories: large gram-positive rods (Lactobacillus morphotypes) scored 0 to 4 inversely, so abundant Lactobacillus lowers the score; small gram-variable rods and coccobacilli (Gardnerella and Bacteroides morphotypes) scored 0 to 4; and curved gram-variable rods (Mobiluncus morphotypes) scored 0 to 2. Those two scores rise with the abundance of the morphotype. The total ranges from 0 to 10: 0-3 is normal, 4-6 is intermediate, and 7-10 is consistent with BV. Morphotype labels are not species identifications. Intermediate flora is a transitional pattern. In a cohort of 7,918 pregnant women, 32% of those with intermediate flora had acquired BV and 30% had shifted to normal flora at follow-up.4 The method is high-complexity and training dependent.3,2

The Amsel clinical criteria require at least 3 of 4 findings: homogeneous thin discharge coating the vaginal walls; clue cells (epithelial cells stippled with adherent bacteria) on wet mount; vaginal pH greater than 4.5; and a fishy amine odor after addition of 10% KOH (whiff test). Amsel sensitivity is 37% to 70% against Nugent, with specificity 94% to 99%, so a negative Amsel assessment does not exclude BV.3

Molecular panels cleared by the Food and Drug Administration (FDA) now provide the most sensitive class of test among symptomatic women, outperforming clinician assessment, on-site microscopy, and Nugent interpretation, particularly for mixed infections. Performance is analyte- and device-specific. The BD MAX Vaginal Panel targets a BV algorithm (L. crispatus, L. jensenii, Gardnerella vaginalis, F. vaginae, BVAB2, Megasphaera type 1) plus Candida species groups and T. vaginalis. The Cepheid Xpert Xpress MVP targets a BV algorithm (Atopobium species, BVAB2, Megasphaera-1) plus Candida and T. vaginalis. The Hologic Aptima BV and Aptima CV/TV assays cover the same spectrum in two separate tests. A positive molecular result detects target nucleic acid and does not establish that the organism is causing disease, because Candida and BV-associated organisms also colonize asymptomatic women. The panels are intended for symptomatic patients. They are not intended for routine screening.2

Culture of Gardnerella is not a diagnostic test for BV, because the organism is recoverable from approximately half of asymptomatic women. Redirect a request for BV culture to Nugent-scored Gram stain, a complete Amsel assessment, or a validated multi-organism NAAT.2

Classic Gardnerella vaginalis is a small pleomorphic gram-variable coccobacillus, catalase-negative and oxidase-negative, that grows on enriched media at 35 to 37 °C in 5% CO2 over 24 to 48 hours. The classic presumptive reaction is diffuse beta-hemolysis on human-blood bilayer Tween agar. Sheep blood gives poor growth and little or no visible hemolysis. Beta-lactamase production is not an established identification or reporting characteristic, and no CLSI susceptibility method or breakpoint exists for the genus, so routine antimicrobial susceptibility testing (AST) of a vaginal isolate is not indicated.1

Vulvovaginal candidiasis and trichomoniasis

Vulvovaginal candidiasis is supported by budding yeast, hyphae, or pseudohyphae on saline or 10% KOH wet preparation. Vaginal pH is usually below 4.5. Microscopy sensitivity is roughly 40% to 80%, so a negative wet mount does not exclude the diagnosis. Culture remains the reference standard. Obtain it for recurrent, severe, or refractory disease to identify non-albicans yeast. Nakaseomyces glabratus (formerly Candida glabrata) does not form hyphae or pseudohyphae and is easily missed microscopically. Detection alone does not prove disease, because 10% to 20% of women harbor vaginal yeast without symptoms.3,2

T. vaginalis trophozoites are pyriform, 7 to 30 micrometers, with four anterior flagella and one posterior flagellum along an undulating membrane about half the body length. There is no cyst form. A fresh 0.9% saline wet mount is examined immediately for jerky motility. Sensitivity is 44% to 68% versus culture and falls to about 20% within 1 hour. NAAT is the most sensitive test and is now standard. Culture (InPouch TV, examined daily over 5 of 7 days) remains available when a viable isolate is needed for suspected nitroimidazole resistance. The OSOM Trichomonas Rapid Test is an immunochromatographic antigen assay with sensitivity 82% to 95% in women. It is not adequate in men. Wait at least 3 weeks after treatment before repeating a NAAT, because residual nucleic acid may be detected. CDC recommends annual Trichomonas screening for all women with HIV. Morphology details of the trophozoite are covered in the parasitology lessons.3,2

Endocervical and urethral specimens, and the NAAT-versus-culture decision

For NAAT screening, the Centers for Disease Control and Prevention (CDC) specifies the optimal urogenital specimens: a vaginal swab for women, which may be self-collected in a clinical setting, and first-catch urine for men. An endocervical swab is an acceptable alternative in women. Swab material, insertion depth, rotation, and the interval since last void are assay-specific and follow each manufacturer's instructions. Several FDA-cleared assays detect N. gonorrhoeae and C. trachomatis simultaneously, and several are also cleared for rectal and pharyngeal swabs, enabling site-based screening in men who have sex with men. A laboratory using an assay at a site or specimen type outside its cleared intended use establishes and documents its own performance specifications under the Clinical Laboratory Improvement Amendments (CLIA; 42 CFR 493.1253(b)(2)). That is a separate obligation from verifying an unmodified cleared test.5,2

NAAT is the recommended test because its sensitivity exceeds that of culture. It is not universally more specific, and some gonococcal NAATs cross-react with commensal Neisseria in oropharyngeal specimens, where the assay's site-specific performance must be checked. Culture is retained to recover an isolate in suspected treatment failure, disseminated infection, conjunctivitis, medicolegal cases, and public-health surveillance.5,2

For gonococcal culture, an endocervical or urethral swab is collected after removing surface mucus, using a rayon, Dacron, or calcium alginate tip on a plastic or wire shaft. Cotton tips and wooden shafts can inhibit the organism. Direct bedside inoculation onto modified Thayer-Martin or Martin-Lewis medium in a CO2-generating system such as JEMBEC or Gono-Pak is optimal. Sterile-site specimens (blood, synovial fluid, cerebrospinal fluid) are also plated to nonselective chocolate agar, because the vancomycin in selective media inhibits some gonococcal strains. Incubate at 35 to 36.5 °C in approximately 5% CO2 with humidity and examine at 24 and 48 hours. The organism is fragile. It survives in swab transport media at room temperature for no more than about 1 hour. Never refrigerate it in transit.5,2

Gonococcal identification and susceptibility testing

A urethral Gram stain showing intracellular gram-negative diplococci within neutrophils is presumptively diagnostic in symptomatic men, with sensitivity greater than 95% and specificity greater than 99%. It is inadequate for asymptomatic men and is not recommended for cervical, rectal, or pharyngeal specimens. Colonies are small, gray to pink-brown, oxidase-positive, and do not grow on MacConkey agar. Gram-negative diplococci with a positive oxidase test from selective genital media remain only a presumptive identification, because N. meningitidis, N. lactamica, Kingella denitrificans, and Moraxella catarrhalis share this profile. A strong superoxol reaction (30% hydrogen peroxide) supports the identification. Carbohydrate utilization or a validated commercial or molecular method, including MALDI-TOF, confirms the species. N. meningitidis can also cause urethritis and is indistinguishable from N. gonorrhoeae on Gram stain.

Susceptibility testing uses GC agar base with 1% defined growth supplement, since the organism grows unreliably on Mueller-Hinton agar, incubated at 35 to 36.5 °C in 5% CO2 for 20 to 24 hours. CLSI M100 (36th edition, 2026) now provides intermediate and resistant categories for ceftriaxone (S less than or equal to 0.12, I 0.25, R greater than or equal to 0.5 micrograms per milliliter) and cefixime (S less than or equal to 0.06, I 0.12, R greater than or equal to 0.25), replacing the earlier susceptible-only interpretive criteria. Disk-diffusion breakpoints for these two agents were removed pending review. Agar dilution is the reference method. Preserve isolates from suspected treatment failure and refer them to the public health laboratory, and report suspected cephalosporin treatment failure to public health within 24 hours.6,5

Gonorrhea is nationally notifiable. Chlamydia is also notifiable in every state. The laboratory reports to the local health jurisdiction according to state law.5

Genital ulcer disease

Organism Disease Optimal test Notes
Herpes simplex virus Vesicular/ulcerative genital lesions NAAT of vesicle fluid or ulcer-base swab in viral transport medium; multiple FDA-cleared assays exist Type-specific glycoprotein G IgG serology documents prior infection and is not used to diagnose an acute lesion, and IgM serology is not useful. Direct fluorescent-antibody kits are no longer commercially available in the United States; viral culture is the remaining alternative but is slower and less sensitive
Treponema pallidum Primary syphilitic chancre Darkfield microscopy of lesion exudate, or serology; PCR is available at reference laboratories Painless, indurated, single ulcer with a clean base is classic
Haemophilus ducreyi Chancroid (painful genital ulcer) Primarily clinical diagnosis; no FDA-cleared NAAT exists, and culture sensitivity is below 80%. Culture requires GC agar base enriched with hemoglobin, serum, and an enrichment supplement, incubated at the lower temperature of 33 °C in 5% CO2 with high humidity The classic Gram stain shows small gram-negative coccobacilli in parallel chains ("school of fish"), but direct smears are unreliable. H. ducreyi is now also recognized as a major cause of non-sexually-transmitted cutaneous ulcers in children in tropical, yaws-endemic regions
C. trachomatis serovars L1-L3 Lymphogranuloma venereum (LGV) NAAT of lesion exudate, rectal swab, or lymph-node aspirate; several assays are FDA-cleared for rectal specimens A positive general C. trachomatis NAAT does not distinguish LGV serovars; definitive confirmation requires LGV-specific genotyping at a reference laboratory, and treatment is not withheld pending it. Complement fixation and microimmunofluorescence serology have no standardized interpretation, so neither is used routinely
Klebsiella granulomatis (formerly Calymmatobacterium granulomatis) Granuloma inguinale (donovanosis) Crush preparation from the ulcer margin, Wright or Giemsa stain, looking for intracellular safety-pin-shaped Donovan bodies Does not grow on routine media; molecular assays exist but are not commercially available. Donovan-body-like structures can be mimicked by artifact, so biopsy with histopathology is the fallback when smear is negative but suspicion persists

Treponema pallidum and the treponematoses

Treponema pallidum subsp. pallidum causes venereal syphilis, subsp. pertenue causes yaws, and subsp. endemicum causes endemic syphilis (bejel). The related species T. carateum causes pinta. Pathogenic treponemes cannot be cultured on artificial media, so diagnosis depends on direct visualization early and serology thereafter.

Stage Timing Findings
Primary Median 3 weeks post-inoculation Painless indurated chancre (may be unnoticed or absent in previously infected patients); regional non-suppurative lymphadenopathy
Secondary ~6 weeks post-inoculation (range 2-12 weeks) Widespread mucocutaneous rash including palms and soles, condyloma lata, generalized lymphadenopathy, constitutional symptoms; mucous patches
Latent Early (first year) vs. late Asymptomatic; early latent relapses are possible, late latent relapse is uncommon
Tertiary 10-25 years after infection Cardiovascular syphilis (ascending aortic aneurysm, aortic insufficiency), gummas, meningovascular or parenchymal neurosyphilis
Congenital Early (before 2 years) or late (after a latent period) Risk and severity correlate with the stage of maternal infection (highest with primary, secondary, or early latent disease) and gestational timing

Darkfield microscopy on serous exudate from a cleaned, abraded primary or secondary lesion visualizes motile spirochetes within about 20 minutes of collection. Motility is required for identification because treponemes are too narrow for conventional light microscopy. Darkfield microscopy is unreliable on oral lesions because morphologically similar commensal oral treponemes are present. Immunohistochemical staining of paraffin-embedded tissue is an alternative where darkfield is unavailable.

Nontreponemal and treponemal serologic testing, algorithm interpretation, and neurosyphilis serologic criteria are covered in Immunology. T. pallidum remains uniformly susceptible to penicillin. A 23S rRNA mutation can confer high-level macrolide resistance.

Chlamydia

Chlamydiae are obligate intracellular bacteria that depend on the host cell for replication. They have been called energy parasites because reticulate bodies primarily scavenge host ATP through ATP/ADP translocases. Elementary bodies generate their own ATP, largely from imported glucose-6-phosphate. Two morphologic forms alternate through the developmental cycle: the infectious, non-dividing but metabolically active elementary body and the intracellular, replicating reticulate body. Under stress such as nutrient deprivation or cell-wall-active antibiotics, reticulate bodies enlarge into non-dividing aberrant bodies, a reversible state called persistence that explains chronic and recurrent disease. Taxonomically, all species have been returned to the single genus Chlamydia after the former Chlamydophila split (1999) was reversed (2015). At least six species have caused documented human infection: C. trachomatis, C. pneumoniae, and the zoonotic species C. psittaci, C. abortus, C. caviae, and C. felis.7

C. trachomatis serovars sort into three disease groups: A through C cause trachoma, D through K cause urogenital infection, and L1 through L3 cause lymphogranuloma venereum.

Category Disease Notes
Classic trachoma Recurrent conjunctival infection, progressing to scarring, entropion, trichiasis, and corneal blindness Endemic where sanitation and hygiene are poor; WHO grades progression as TF (follicular inflammation), TI (intense inflammation), TS (scarring), TT (trichiasis), and CO (corneal opacity)
Sexually transmitted, non-LGV (serovars D-K) Urethritis and cervicitis, often asymptomatic; ascending disease (PID, salpingitis, perihepatitis or Fitz-Hugh-Curtis syndrome); reactive arthritis Most common reportable infection in the United States
LGV (serovars L1-L3) Genital ulcer with suppurative regional lymphadenopathy progressing to fibrotic strictures; proctocolitis with rectal transmission Only C. trachomatis disease with prominent systemic involvement
Perinatal (serovars D-K) Inclusion conjunctivitis 5-12 days after birth; subacute afebrile pneumonitis at 1-3 months, with staccato cough and often peripheral eosinophilia Acquired during vaginal delivery through an infected birth canal

NAAT is the diagnostic method of choice for urogenital C. trachomatis infection in symptomatic and asymptomatic patients: vaginal swab or first-void urine in women, first-catch urine in men. Rectal and oropharyngeal infection requires a specimen from the exposure site on a platform whose labeling or validated performance supports that site. Routine oropharyngeal C. trachomatis screening is not recommended because prevalence is low and clinical significance is unclear. Routine test-of-cure is not advised for nonpregnant patients treated with a recommended regimen. If test-of-cure is indicated (pregnancy, or concern for treatment failure), use NAAT no earlier than 4 weeks after therapy, because residual nucleic acid from nonviable organisms causes false positives. Retest all treated patients at approximately 3 months for reinfection.5

For suspected sexual assault or abuse in prepubertal children, CDC 2021 permits culture or an FDA-cleared NAAT, with expert consultation and confirmation of every initially positive result by retesting the original specimen or a second specimen, because of the legal consequences of a false positive. Specimens are collected from the pharynx and rectum, plus the vagina in girls or urine in boys. Cervical specimens are not collected in prepubertal girls. Preserve pre-treatment specimens and isolates.5

For neonatal conjunctivitis, DFA remains the only FDA-cleared nonculture method for conjunctival C. trachomatis as of 2026, and NAATs are not FDA-cleared for conjunctival swabs. A laboratory using a NAAT on that off-label specimen must establish performance specifications under CLIA. In genital specimens, NAAT replaces DFA. Serology has little diagnostic value for genital infection because antibody persists long after resolution, but a single IgM titer of 1:32 or higher by microimmunofluorescence supports infant pneumonitis. The test is available mainly as a reference-laboratory send-out. C. psittaci and C. pneumoniae are now diagnosed most often by NAAT. No FDA-cleared NAAT exists for C. psittaci, which is tested at CDC or by laboratory-developed test, and handling of avian-origin material warrants BSL-3 practices. The CSTE 2010 case definition, which confirms psittacosis by culture or a fourfold IgG rise and classifies a single IgM of 1:32 or PCR detection as probable, is scheduled for replacement in January 2027 by a molecular-first definition, with psittacosis removed from the nationally notifiable list.5,8

Genital mycoplasmas and Mycoplasma pneumoniae

Ureaplasma species and Mycoplasma hominis may colonize the vagina and cervix. Colonization does not indicate disease, but their presence in placental membranes or amniotic fluid is associated with chorioamnionitis, preterm birth, and neonatal pneumonia or sepsis. M. genitalium is a cause of nongonococcal, nonchlamydial urethritis in men and cervicitis in women.

Organism Best diagnostic method Notes
M. hominis Culture or NAAT. On sheep blood and chocolate agar it grows slowly, over 2 to 5 days, as tiny translucent nonhemolytic pinpoint colonies easily mistaken for streptococci, and the organism lacks a cell wall and is Gram-stain invisible. Classic fried-egg colonies are seen on specialized media (SP4, A7, A8). It also grows in blood-culture broth without visible turbidity Metabolizes arginine through the arginine dihydrolase pathway, producing ammonia and an alkaline shift (yellow to pink-red with phenol red)
Ureaplasma species (U. urealyticum and U. parvum, which most assays report together) Culture on A7 (Shepard) or A8 differential agar, or NAAT. Urease-positive colonies appear as small golden-brown to black granular colonies over 24 to 72 hours as manganese in the medium precipitates around growth Optimal growth pH approximately 5.7 to 6.8, versus approximately 7.2 to 7.4 for M. hominis; separate media were used historically, and combined systems now exist
M. genitalium NAAT only. Culture is impractical because the organism grows as slowly and fastidiously as M. pneumoniae. FDA-authorized NAATs include the Aptima M. genitalium assay (De Novo DEN180047, 2019; urine, urethral, penile meatal, endocervical, and vaginal swabs) and cobas TV/MG (510(k) K190433, May 2019; urine, vaginal and endocervical specimens, and meatal swabs), each used only for its own cleared specimen types13,14 CDC recommends testing only when a clinical indication exists, such as persistent nongonococcal urethritis or recurrent cervicitis. Routine screening of asymptomatic persons is not recommended
M. pneumoniae NAAT (single or multiplex respiratory panel) is optimal; culture is rarely offered (1 to 6 weeks; small granular mulberry-shaped colonies that differ from the fried-egg colonies of M. hominis) Serology and cold agglutinins (traditionally 1:64 or higher) remain available but are nonspecific and largely superseded by molecular testing

Because all Mollicutes lack a peptidoglycan cell wall, every Mycoplasma and Ureaplasma species is intrinsically resistant to all beta-lactams and glycopeptides, and to sulfonamides, trimethoprim, and rifampin. These agents are never reported as treatment options. Macrolide resistance in M. genitalium arises from point mutations in domain V of 23S rRNA at positions homologous to Escherichia coli 2058 and 2059. Fluoroquinolone resistance arises from parC mutations, sometimes with gyrA. M. pneumoniae macrolide resistance is also 23S rRNA mediated. M. hominis is intrinsically resistant to 14- and 15-membered macrolides, and Ureaplasma is intrinsically clindamycin-resistant. Macrolide-resistance-marker assays support resistance-guided therapy but are available in the United States only as laboratory-developed tests.5

Organism Typical specimen Representative gene targets Other diagnostic methods
Treponema pallidum Genital ulcer, blood, CSF, placenta/fetal tissue polA, 16S rRNA, membrane protein genes Serology remains central, through the traditional or reverse algorithm; darkfield and DFA are direct methods for suitable lesion specimens
Neisseria gonorrhoeae NAAT: first-void urine or vaginal, cervical, or urethral swab as labeled; exposure-site rectal or pharyngeal swab where the assay supports it; culture from endocervical, urethral, or sterile-site specimens when an isolate is needed Assay-specific targets: opa family or other chromosomal targets, pilin-related targets, 16S rRNA, DR-9 region Culture
Chlamydia trachomatis NAAT: vaginal swab or first-catch urine (women), first-catch urine (men); rectal swab for rectal exposure Assay-specific: cryptic plasmid, 23S rRNA, MOMP gene, 16S rRNA Culture, EIA, DFA
Mycoplasma genitalium Urine, urethral, vaginal, or cervical swab MgPa adhesin gene, rDNA Culture (essentially unavailable)
Mycoplasma hominis, Ureaplasma species Genital tract, amniotic fluid 16S rRNA, urease gene Culture
Haemophilus ducreyi Genital ulcer groEL, 16S-23S intergenic spacer Gram stain, culture, serology

Group B Streptococcus screening

Universal antepartum screening for Streptococcus agalactiae (group B Streptococcus, GBS) colonization is performed at 36 0/7 to 37 6/7 weeks of gestation. A screen is not collected when intrapartum prophylaxis is already indicated because GBS bacteriuria was found in the current pregnancy at any concentration, or because a previous infant had invasive GBS disease. A negative culture is considered valid for 5 weeks. If delivery has not occurred by 41 0/7 weeks, repeating a previously negative screen is reasonable. The specimen is one swab, preferably flocked, that samples the lower vagina near the introitus and then the rectum through the anal sphincter, without a speculum. Two separate swabs are also acceptable, and self-collection after instruction can produce comparable yield. Vaginal sampling alone under-detects colonization. Place the swab in Stuart or Amies transport medium and deliver it within 24 hours. Refrigerate an Amies specimen at 4 to 8 °C if transport is delayed.9,10

Inoculate the swab into a selective enrichment broth and incubate it 18 to 24 hours at 35 to 37 °C in ambient air or 5% CO2 before subculture. Lim broth is Todd-Hewitt broth with colistin 10 micrograms per milliliter and nalidixic acid 15 micrograms per milliliter. Trans-Vag broth is a distinct formulation, Todd-Hewitt broth with gentamicin 8 micrograms per milliliter and nalidixic acid 15 micrograms per milliliter. Enrichment roughly doubles recovery compared with direct plating, and ASM 2021 guidance considers direct plating alone unacceptable for the antepartum screen. Abundant Enterococcus faecalis can nevertheless suppress GBS in broth, so direct agar inoculation is an adjunct. Subculture is to sheep blood agar, CNA agar, or a validated chromogenic medium.10

After enrichment, candidate colonies are usually larger than 0.5 mm at 24 hours, gray to white and translucent, with a narrow zone of beta-hemolysis or no hemolysis. Approximately 5% to 6% of screening isolates are nonhemolytic, so examine plates at 24 hours and again at 48 hours. Pigment-based media such as Granada miss nonhemolytic strains. GBS appears as gram-positive cocci in chains on Gram stain and is catalase-negative. CAMP and hippurate hydrolysis are traditional presumptive tests. The CAMP factor (Cfb) is itself nonhemolytic and synergizes with the beta-lysin of a beta-hemolytic S. aureus strain to produce the arrowhead zone. Current identification uses MALDI-TOF MS or a group B latex method. Latex reagents cross-react with S. pseudoporcinus and S. halichoeri. A PYR test resolves the cross-reaction, because S. agalactiae is PYR-negative. Up to 31% of target-colored colonies on chromogenic media are not GBS, so candidate colonies require confirmation.10

NAAT on the enriched broth is an acceptable alternative, but direct-specimen NAAT is not recommended for antepartum screening because reported false-negative rates range from 6.3% to 22%.10 The FDA-cleared Cepheid Xpert Xpress GBS assay (510(k) K222638, cleared September 27, 2023) is labeled for direct vaginal/rectal swab testing at intrapartum in term patients whose antepartum screening result is unknown or unavailable and who have no additional risk factors warranting empiric prophylaxis. Its negative result is presumptive and cannot exclude colonization, and it yields no isolate, so culture is still required when susceptibility testing is needed.15,16

A positive screen documents maternal colonization and generally indicates intrapartum prophylaxis to prevent early-onset neonatal GBS disease, except with prelabor cesarean delivery and intact membranes. Screening and prophylaxis do not prevent late-onset disease. For a patient with high-risk penicillin allergy (immediate anaphylaxis or a severe rare delayed non-IgE reaction), the isolate is tested for clindamycin and erythromycin susceptibility under current CLSI M100. Erythromycin results are the screen for inducible clindamycin resistance, and when erythromycin is resistant with clindamycin susceptible, an inducible-resistance test is performed and clindamycin is reported resistant if the D-zone is present. Report the clindamycin result. Erythromycin is tested only as the screen for inducible resistance and is not reported for prophylaxis. Routine penicillin or cefazolin AST is not required, because GBS remains predictably susceptible to both. The D-test method is covered with antimicrobial susceptibility testing.9,11,10 At the bench, check the specimen source before you interpret an isolate, because the same organism can be a pathogen in deep tissue and a colonizer on a surface swab.

Practice

Check yourself 1 of 3

A surface swab of a chronic leg ulcer grows Pseudomonas aeruginosa, two lactose-fermenting gram-negative rods, and mixed skin flora, with no Staphylococcus aureus or beta-hemolytic streptococci. How is the culture reported?

Incorrect. A polymicrobial surface culture of a chronic ulcer reflects colonizers, and working up every isolate cannot show which organism, if any, is invading.

Correct. A surface culture of a chronic ulcer reflects colonizers. The report states mixed flora, with a note that full identification and susceptibility testing is not indicated and a request for deep tissue or an aspirate taken after debridement. P. aeruginosa and the Enterobacterales are significant from deep tissue.

Incorrect. P. aeruginosa is a common colonizer of superficial chronic wounds, so a surface swab cannot show that it is invading, and its significance has to be judged from a deeper specimen.

Review this section

Check yourself 2 of 3

A clinician orders a vaginal culture for Gardnerella to diagnose bacterial vaginosis (BV). What does the laboratory do?

Incorrect. Gardnerella is recoverable from about half of asymptomatic women, so its growth in culture is not a diagnostic test for BV.

Correct. Gardnerella culture is not a diagnostic test for BV. Nugent scoring is the reference laboratory method (0 to 3 normal, 4 to 6 intermediate, 7 to 10 consistent with BV), a complete Amsel assessment needs 3 of 4 criteria, and FDA-cleared multi-organism panels are intended for symptomatic patients.

Incorrect. No CLSI method or breakpoint exists for the genus, so routine susceptibility testing of a vaginal isolate is not indicated, and culture does not diagnose BV.

Review this section

Check yourself 3 of 3

A vaginal-rectal swab for antepartum group B streptococcus (GBS) screening arrives. Which processing is acceptable?

Incorrect. Enrichment roughly doubles recovery, and ASM 2021 guidance considers direct plating alone unacceptable for the antepartum screen.

Incorrect. Direct NAAT has reported false-negative rates of 6.3% to 22% for antepartum screening and yields no isolate for susceptibility testing when it is needed.

Correct. Enrichment in selective broth such as Lim or Trans-Vag roughly doubles recovery compared with direct plating, and reading the subculture at 24 and 48 hours detects the 5% to 6% of screening isolates that are nonhemolytic.

Review this section

References
  1. Tille PM. Bailey & Scott's Diagnostic Microbiology. 16th ed. Elsevier; 2025. Back to text
  2. Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. Published online March 5, 2024. doi:10.1093/cid/ciae104 Back to text
  3. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. Bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. Accessed August 31, 2026. https://www.cdc.gov/std/treatment-guidelines/bv.htm Back to text
  4. Hillier SL, Krohn MA, Nugent RP, Gibbs RS. Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Am J Obstet Gynecol. 1992;166(3):938-944. doi:10.1016/0002-9378(92)91368-k Back to text
  5. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. Chlamydial infections, gonococcal infections, and mycoplasma genitalium. Accessed August 31, 2026. https://www.cdc.gov/std/treatment-guidelines/chlamydia.htm Back to text
  6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 36th ed. CLSI supplement M100. CLSI; 2026. Back to text
  7. Marti H, Shima K, Boutin S, et al. Zoonotic and other veterinary chlamydiae: an update. Pathog Dis. 2024;82(3):ftae030. doi:10.1093/femspd/ftae030 Back to text
  8. Council of State and Territorial Epidemiologists. Position statement 26-ID-06: update to standardized surveillance case definition for and discontinuation of national notification of psittacosis. 2026. Accessed August 31, 2026. https://cdn.ymaws.com/www.cste.org/resource/resmgr/2014ps/26-ID-06_Psittacosis.pdf Back to text
  9. American College of Obstetricians and Gynecologists. Prevention of group B streptococcal early-onset disease in newborns. ACOG Committee Opinion No. 797. Obstet Gynecol. 2020;135(2):e51-e72. doi:10.1097/AOG.0000000000003668 Back to text
  10. Filkins L, Hauser J, Robinson-Dunn B, et al. Guidelines for the detection and identification of group B Streptococcus. American Society for Microbiology; updated July 23, 2021. Accessed August 31, 2026. https://asm.org/getcontentasset/87c90ce7-5cef-4191-9c36-529b1212242a/dfc3d011-8f63-43f6-9ed8-4b444333a1d0/asm-gbs-guideline.pdf Back to text
  11. Rosa-Fraile M, Spellerberg B. Reliable detection of group B Streptococcus in the clinical laboratory. J Clin Microbiol. 2017;55(9):2590-2598. doi:10.1128/JCM.00582-17 Back to text
  12. Biswas D, Pawar N, Patro SK, Krishna NS, Parida D, Bhagtana PK. Clinical profile and spectrum of bacteriuria in patients with diabetes: an analytical study. J Family Med Prim Care. 2022;11(6):3190-3195. doi:10.4103/jfmpc.jfmpc_1779_21 Accessed September 11, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC9480669/ Quantitative microscopy relationship: an uncentrifuged Gram smear shows at least one organism per oil-immersion field at a bacterial count above 105 CFU/mL. Back to text
  13. U.S. Food and Drug Administration. De Novo classification request DEN180047: Aptima Mycoplasma genitalium assay (Hologic). Decision summary. Accessed September 13, 2026. https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN180047.pdf Back to text
  14. U.S. Food and Drug Administration. 510(k) K190433: cobas TV/MG for use on cobas 6800/8800 systems (Roche Molecular Systems). Clearance letter and indications for use, May 22, 2019. Accessed September 13, 2026. https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190433.pdf Back to text
  15. U.S. Food and Drug Administration. 510(k) K222638: Xpert Xpress GBS (Cepheid). Clearance letter and indications for use, September 27, 2023. Accessed September 13, 2026. https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222638.pdf Back to text
  16. Cepheid. Xpert Xpress GBS instructions for use, 303-1853 Rev B. Accessed September 13, 2026 Back to text

Microbiology, lesson 7 of 19

End of Wound, Tissue, and Genital Tract Bacteriology

Practice this lesson

Back to top
More about this lesson